Correlation Between Silence Therapeutics and Phathom Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Silence Therapeutics and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silence Therapeutics and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silence Therapeutics PLC and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Silence Therapeutics and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silence Therapeutics with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silence Therapeutics and Phathom Pharmaceuticals.

Diversification Opportunities for Silence Therapeutics and Phathom Pharmaceuticals

0.63

Correlation Coefficient

Silence Therapeutics  Phathom Pharmaceuticals

Poor diversification

The 3 months correlation between Silence and Phathom is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Silence Therapeutics PLC and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Silence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silence Therapeutics PLC are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Silence Therapeutics i.e., Silence Therapeutics and Phathom Pharmaceuticals go up and down completely randomly.

Pair Corralation between Silence Therapeutics and Phathom Pharmaceuticals

Considering the 90-day investment horizon Silence Therapeutics is expected to generate 3.04 times less return on investment than Phathom Pharmaceuticals. But when comparing it to its historical volatility, Silence Therapeutics PLC is 2.97 times less risky than Phathom Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  276.00  in Phathom Pharmaceuticals on May 2, 2025 and sell it today you would earn a total of  595.00  from holding Phathom Pharmaceuticals or generate 215.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Silence Therapeutics PLC  vs.  Phathom Pharmaceuticals

Silence Therapeutics PLC

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Silence Therapeutics PLC are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady essential indicators, Silence Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Phathom Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Phathom Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Phathom Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Silence Therapeutics and Phathom Pharmaceuticals

The main advantage of trading using opposite Silence Therapeutics and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silence Therapeutics position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.

The idea behind Silence Therapeutics PLC and Phathom Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.